Pharmafile Logo
Pharmafocus logo
Advanced Search

Fresenius

Showing 6 posts of 6 posts found.

bad_homburg_fresenius_zentrale

Akorn CEO resigns after $4.3bn Fresenius deal falls through

December 10, 2018
Sales and Marketing Akorn, CEO, Fresenius, M&A, MA, Raj Rai, court, generics

The CEO of American generics firm Akorn Inc has stepped down following a ruling from the Delaware Supreme Court declaring …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

April 27, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, FDA, Fresenius, Shire, Takeda, arthritis, pharma

The year seems like it’s running away as we come to the end of April. It’s been a more tense …

News

Fresenius confirms takeover talks with Akorn

April 10, 2017
Sales and Marketing Akorn, Fresenius

Fresenius, Europe’s largest publicly traded healthcare provider, has engaged in discussions with Akorn, a pharmaceutical generics drugmaker, with a view …

News
Abbott image

Abbott buys Russian firm Veropharm

December 15, 2014
Manufacturing and Production, Sales and Marketing Abbott, Fresenius, cfr pharma, petrovax, sistema, veropharm, zenitco

Abbott has completed its purchase of Russia-based Veropharm in a $305 million deal as it looks to firmly establish itself …

News

FDA warns Fresenius Kabi over plant problems

August 27, 2013
Manufacturing and Production FDA, Fresenius, kabi, recall

German drugmaker Fresenius has been sent another warning letter by the US Food and Drug Administration, this time for a …

News

Glass contamination prompts Fresenius recall

July 4, 2013
Manufacturing and Production Fresenius, recall

The US subsidiary of German drugmaker Fresenius has recalled a drug used in the treatment of Parkinson’s disease because of …

News

Latest content

Abcuro completes enrolment for phase 2/3 IBM treatment trial

June 26, 2024

AskBio initiates phase 2 Parkinson’s trial recruitment

June 26, 2024

AstraZeneca’s Tagrisso approved in Japan for lung cancer treatment

June 25, 2024

ILiAD Biotechnologies announces collaboration with Emmes Group on phase 3 pertussis vaccine trial

June 25, 2024

GSK’s Jemperli accepted for review by EMA for endometrial cancer treatment

June 24, 2024